References
- Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, . Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum 2004;33:294–301.
- Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, . Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009;61:1454–61.
- Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum 2004;33:289–93.
- Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996;35:1161–8.
- Younge BR, Cook BE Jr, Bartley GB, Hodges DO, Hunder GG. Initiation of glucocorticoid therapy: before and after temporal artery biopsy. Mayo Clin Proc 2004;79:483–91.
- Wolfgang A, Schmidt MD. Current diagnosis and treatment of temporal arteritis. Curr Treat Options Cardiovasc Med 2006;8:145–51.
- Czihal M, Zanker S, Rademacher A, Tatò F, Kuhlencordt PJ, Schulze-Koops H, . Sonographic and clinical pattern of extracranial and cranial giant cell arteritis. Scand J Rheumatol 2012;41:231–6.
- Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S, Garcia-Porrua C, Sanchez-Andrade A, Paz-Carreira J, . Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore) 2005;84:277–90.
- Kreiner F, Galbo H. Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica. Scand J Rheumatol 2010;39:402–8.
- Baerlecken NT, Linnemann A, Gross WL, Moosig F, Gonzalez-Gay M, Witte T, . Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica. Ann Rheum Dis 2012;71:943–7.
- Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, . The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122–8.
- Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434–9.
- Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 198297:672–80.
- Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, . 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569–81.
- Jennette JC, Falk RJ, Andrassy K. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187–92.
- Kyle V, Cawston TE, Hazelman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989;48:667–71.
- Luqmani RA. Assessing disease activity in the systemic vasculitides. Curr Opin Rheumatol 2002;14:23–8.